Target intelligence / Profile preview

Pathogenic intestinal bacteria – adhesion and niche competition

Molecular classification
Biological Process, Microbial Interaction
01

Overview

Pathogenic intestinal bacteria adhesion and niche competition represent a critical biological interface where enteric pathogens interact with the host epithelium and resident microbiota. Adhesion is the initial step of pathogenesis, where bacteria utilize specialized surface proteins called adhesins to bind to host cell receptors, facilitating colonization and toxin delivery (Ribet & Cossart, 2015, PubMed: 25541216). Niche competition, or colonization resistance, is the process by which commensal microbes prevent pathogen overgrowth by competing for limited nutrients and physical space within the gut (Buffie & Pamer, 2013, PubMed: 23663784). Therapeutic interventions targeting these mechanisms aim to either block bacterial attachment using anti-adhesion molecules or restore the competitive balance through probiotics and fecal microbiota transplants. For example, small molecule inhibitors like sibofimloc target the FimH adhesin on E. coli to prevent inflammation in Crohn's disease (Enterome, 2024). Understanding these interactions is vital for developing non-antibiotic strategies to combat gastrointestinal infections and dysbiosis-related disorders.

Other names
Colonization resistanceBacterial attachmentCompetitive exclusionMicrobial interferenceBacterial adhesion
02

Mechanism of action

Competitive exclusion, physical blocking of epithelial receptors, nutrient sequestration, production of antimicrobial bacteriocins, and pharmacological inhibition of bacterial adhesins.

03

Biological functions

Colonization resistanceBacterial pathogenesisNutrient competitionMucosal immunityBiofilm formation
04

Disease associations

InfectionInflammatory Bowel DiseaseIrritable Bowel SyndromeClostridioides difficile infectionDiarrhea
05

Safety considerations

Risk of systemic infection in immunocompromised patientsDisruption of commensal floraPotential for horizontal gene transfer of antibiotic resistance genesVariable efficacy due to host microbiome heterogeneity
06

Interacting drugs

Sibofimloc (EB8018)

4 more in the full profile.

07

Biomarkers

Microbiome diversity indexPathogen load in stoolFecal calprotectinShort-chain fatty acid levels

Beyond the preview

Go deeper on Pathogenic intestinal bacteria – adhesion and niche competition.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pathogenic intestinal bacteria – adhesion and niche competition.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call